Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models.

Fridkis-Hareli M, Storek M, Or E, Altman R, Katti S, Sun F, Peng T, Hunter J, Johnson K, Wang Y, Lundberg AS, Mehta G, Banda NK, Michael Holers V.

Mol Immunol. 2019 Jan;105:150-164. doi: 10.1016/j.molimm.2018.09.013. Epub 2018 Dec 1.

PMID:
30513451
2.

Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus.

Antoniani C, Meneghini V, Lattanzi A, Felix T, Romano O, Magrin E, Weber L, Pavani G, El Hoss S, Kurita R, Nakamura Y, Cradick TJ, Lundberg AS, Porteus M, Amendola M, El Nemer W, Cavazzana M, Mavilio F, Miccio A.

Blood. 2018 Apr 26;131(17):1960-1973. doi: 10.1182/blood-2017-10-811505. Epub 2018 Mar 8.

PMID:
29519807
3.

CRISPR-Cas Gene Editing to Cure Serious Diseases: Treat the Patient, Not the Germ Line.

Lundberg AS, Novak R.

Am J Bioeth. 2015;15(12):38-40. doi: 10.1080/15265161.2015.1103817. No abstract available.

PMID:
26632360
4.

[Patients with spinal cord injuries experience many sequelae].

Lundberg AS, Andersen MK, Kasch H, Hansen RM.

Ugeskr Laeger. 2015 Oct 9;177(43):V06150476. Review. Danish.

PMID:
26509457
5.

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia.

Stone RM, Mazzola E, Neuberg D, Allen SL, Pigneux A, Stuart RK, Wetzler M, Rizzieri D, Erba HP, Damon L, Jang JH, Tallman MS, Warzocha K, Masszi T, Sekeres MA, Egyed M, Horst HA, Selleslag D, Solomon SR, Venugopal P, Lundberg AS, Powell B.

J Clin Oncol. 2015 Apr 10;33(11):1252-7. doi: 10.1200/JCO.2014.57.0952. Epub 2015 Mar 2.

PMID:
25732165
6.

Delirium during psychiatric admission increases mortality in psychiatric patients during and after hospitalization. A nationwide study from 1995 through 2012.

Lundberg AS, Gustafsson LN, Meagher D, Munk-Jørgensen P.

J Psychosom Res. 2014 Sep;77(3):226-31. doi: 10.1016/j.jpsychores.2014.06.003. Epub 2014 Jun 23.

PMID:
25149032
7.

A nationwide study on delirium in psychiatric patients from 1995 to 2011.

Lundberg AS, Okkels N, Gustafsson LN, Larsen JT, Sørensen LU, Munk-Jørgensen P.

Acta Neuropsychiatr. 2014 Aug;26(4):234-9. doi: 10.1017/neu.2013.65.

PMID:
25142292
8.

Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura.

Wu TC, Yang S, Haven S, Holers VM, Lundberg AS, Wu H, Cataland SR.

J Thromb Haemost. 2013 Oct;11(10):1925-7. doi: 10.1111/jth.12369. No abstract available.

9.

[Clinical Psychiatric Research School].

Okkels N, Ahlers FS, Harboe LF, Kjær JN, Mogensen RB, Okkels AS, Østergaard PJ, Lundberg AS.

Ugeskr Laeger. 2013 May 6;175(19):1364. Danish. No abstract available.

PMID:
23833779
10.

Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases.

Fridkis-Hareli M, Storek M, Mazsaroff I, Risitano AM, Lundberg AS, Horvath CJ, Holers VM.

Blood. 2011 Oct 27;118(17):4705-13. doi: 10.1182/blood-2011-06-359646. Epub 2011 Aug 22.

11.

Amonafide: a potential role in treating acute myeloid leukemia.

Allen SL, Lundberg AS.

Expert Opin Investig Drugs. 2011 Jul;20(7):995-1003. doi: 10.1517/13543784.2011.585756. Epub 2011 May 19. Review.

PMID:
21591994
12.

Pharmacokinetics, bioavailability and effects on electrocardiographic parameters of oral fludarabine phosphate.

Yin W, Karyagina EV, Lundberg AS, Greenblatt DJ, Lister-James J.

Biopharm Drug Dispos. 2010 Jan;31(1):72-81. doi: 10.1002/bdd.690.

PMID:
19862681
13.

Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemia.

Allen SL, Kolitz JE, Lundberg AS, Bennett JM, Capizzi RL, Budman DR.

Leuk Res. 2010 Apr;34(4):487-91. doi: 10.1016/j.leukres.2009.07.038. Epub 2009 Sep 12.

PMID:
19748672
14.

Interstitial lung disease following erlotinib (Tarceva) in a patient who previously tolerated gefitinib (Iressa).

Tammaro KA, Baldwin PD, Lundberg AS.

J Oncol Pharm Pract. 2005 Sep;11(3):127-30.

PMID:
16390601
15.

Telomerase contributes to tumorigenesis by a telomere length-independent mechanism.

Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, Modha P, Mizuno H, Brooks MW, Fleming M, Zimonjic DB, Popescu NC, Weinberg RA.

Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12606-11. Epub 2002 Aug 22.

16.

Immortalization and transformation of primary human airway epithelial cells by gene transfer.

Lundberg AS, Randell SH, Stewart SA, Elenbaas B, Hartwell KA, Brooks MW, Fleming MD, Olsen JC, Miller SW, Weinberg RA, Hahn WC.

Oncogene. 2002 Jul 4;21(29):4577-86.

17.

Serum response factor is required for immediate-early gene activation yet is dispensable for proliferation of embryonic stem cells.

Schratt G, Weinhold B, Lundberg AS, Schuck S, Berger J, Schwarz H, Weinberg RA, Rüther U, Nordheim A.

Mol Cell Biol. 2001 Apr;21(8):2933-43.

18.

Genes involved in senescence and immortalization.

Lundberg AS, Hahn WC, Gupta P, Weinberg RA.

Curr Opin Cell Biol. 2000 Dec;12(6):705-9. Review.

PMID:
11063935
19.

Control of the cell cycle and apoptosis.

Lundberg AS, Weinberg RA.

Eur J Cancer. 1999 Dec;35(14):1886-94. Review. No abstract available.

PMID:
10711231
20.

Control of the cell cycle and apoptosis.

Lundberg AS, Weinberg RA.

Eur J Cancer. 1999 Apr;35(4):531-9. Review. No abstract available.

PMID:
10492624
21.

Creation of human tumour cells with defined genetic elements.

Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA.

Nature. 1999 Jul 29;400(6743):464-8.

PMID:
10440377
23.

Regulation of cyclin E transcription by E2Fs and retinoblastoma protein.

Geng Y, Eaton EN, Picón M, Roberts JM, Lundberg AS, Gifford A, Sardet C, Weinberg RA.

Oncogene. 1996 Mar 21;12(6):1173-80.

PMID:
8649818
24.

The role of T-cell receptor beta chain genes in the susceptibility to rheumatoid arthritis.

McDermott M, Kastner DL, Holloman JD, Schmidt-Wolf G, Lundberg AS, Sinha AA, Hsu C, Cashin P, Molloy MG, Mulcahy B, et al.

Ann N Y Acad Sci. 1995 Jul 7;756:173-5. No abstract available.

PMID:
7645823
25.

The role of T cell receptor beta chain genes in susceptibility to rheumatoid arthritis.

McDermott M, Kastner DL, Holloman JD, Schmidt-Wolf G, Lundberg AS, Sinha AA, Hsu C, Cashin P, Molloy MG, Mulcahy B, et al.

Arthritis Rheum. 1995 Jan;38(1):91-5.

PMID:
7818578
26.
27.

Evolution, function, and utilization of major histocompatibility complex polymorphism in autoimmune disease.

McDevitt HO, Wraith DC, Smilek DE, Lundberg AS, Steinman L.

Cold Spring Harb Symp Quant Biol. 1989;54 Pt 2:853-7. Review. No abstract available.

PMID:
2701219
28.
29.

The mutH, mutL, mutS, and uvrD genes of Salmonella typhimurium LT2.

Pang PP, Tsen SD, Lundberg AS, Walker GC.

Cold Spring Harb Symp Quant Biol. 1984;49:597-602. No abstract available.

PMID:
6397314
30.

Laboratory and clinical results with improved methods of preparing fresh and frozen platelet concentrates.

Pert JH, Lundberg AS, Yankee RA, Henderson E, Zucker MB.

Md State Med J. 1968 Sep;17(9):84-5. No abstract available.

PMID:
5681703

Supplemental Content

Loading ...
Support Center